No mRNA Me-Too? CureVac Spies 2021 Launch For COVID-19 Vaccine

EU Backing Gives Company Options

 
• By Andrew McConaghie
  
TUEBINGEN, GERMANY - NOVEMBER 21: (BILD ZEITUNG OUT) the Logo of Curevac is seen on a sign in front of the CUREVAC building on November 21, 2020 in Tuebingen, Germany.
CureVac aims to recruit up at least 30,000 to its Phase IIb/III trial in Europe and Latin America. (DeFodi Images/Getty Images)

More from Business

More from Scrip